This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cohn, J. N. Search for Related Content PubMed PubMed Citation Articles by Cohn, J. N.

Circulation, Vol 78, 1099-1107, Copyright © 1988 by American Heart Association

ARTICLES

Current therapy of the failing heart

JN Cohn
Department of Medicine, University of Minnesota Medical School, Minneapolis 55455.

Myocardial dysfunction eventuating in systolic and diastolic pump function abnormalities is a consequence of a wide variety of cardiac diseases. The symptoms that develop in this syndrome appear to be related as much to peripheral and neurohormonal mechanisms as to the underlying pathological and cardiac functional abnormality. Relief of symptoms, slowing of the progression of the cardiac functional abnormality, and prolongation of life provide the major agenda for the physician faced with the management of these patients. Judicious use of vasodilators, diuretics, digoxin, dietary therapy, and exercise therapy can relieve symptoms and improve the quality of life in most patients suffering from this syndrome. Recent evidence that vasodilator drugs can prolong life now provides the physician with further justification for routine use of this class of compounds. The eventual solution to the high mortality in this common disease process may be prevention of the development of overt heart failure by more prompt recognition and early treatment of the signs of ventricular dysfunction. This possibility must await the completion of current and proposed clinical trials.

This article has been cited by other articles:

				K. A. Johnson, D. J. Partsch, L. L. Rippole, and D. M. McVey Reliability of Self-reported Blood Pressure Measurements Arch Intern Med, December 13, 1999; 159(22): 2689 - 2693. [Abstract] [Full Text] [PDF]

				C. K. Russell, T. Geraci, A. Hooper, L. Shull, and D. M. Gregory Patients' Explanatory Models for Heart Failure and COPD Exacerbations Clin Nurs Res, May 1, 1998; 7(2): 164 - 188. [Abstract] [PDF]

				S. N. Singh, R. D. Fletcher, S. G. Fisher, B. N. Singh, H. D. Lewis, P. C. Deedwania, B. M. Massie, C. Colling, D. Lazzeri, and The Survival Trial of Antiarrhythmic Therapy in Co Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia N. Engl. J. Med., July 13, 1995; 333(2): 77 - 82. [Abstract] [Full Text] [PDF]